Technology Meets Purpose: Transforming Clinical Trials at TruLab with CEO Scott Ogle

01/10/2024 33 min Temporada 1 Episodio 22
Technology Meets Purpose: Transforming Clinical Trials at TruLab with CEO Scott Ogle

Listen "Technology Meets Purpose: Transforming Clinical Trials at TruLab with CEO Scott Ogle"

Episode Synopsis

Summary
In this 22nd episode of BioTalk Unzipped, host Gregory Austin and co-host Chad Briscoe engage with Scott Ogle, CEO of TrueLab, discussing his journey from finance to the pharmaceutical industry, the impact of personal experiences on innovation, and the importance of technology in clinical trials. They explore how to hire the best employees in this climate, the significance of company culture, and the influence of family on business perspectives. 
Chapters
00:00 Introduction to BioTalk Unzipped
03:15 The Impact of Personal Experience on Innovation
08:47 TruLab's Technology and Its Role in Clinical Trials
14:33 The Importance of Sample Management and the Genesis of TruLab
20:33 NEW NEWS! – The Future of Cancer Treatments
23:34 Hiring Patterns and the value of Company Culture
Takeaways

Scott Ogle's personal experience with his father's illness inspired the creation of TruLab.

TruLab focuses on eliminating inefficiencies in clinical trial sample management.

The importance of having fun in one's career for productivity and happiness.

Hiring for energy and cultural fit is crucial for company success.

More young people out of college actually prefer working in the office, so it’s a hiring advantage.


Sound Bites

“Entrepreneurs get excited about their solution but can forget about what problem they’re solving.”

"We need to iterate on technology in clinical trials."

“20-25% of biological samples get tossed out.”

"You can't coach energy in a candidate."

“Company values. Senior leadership must beat it like a drum.”

“Interviewing candidates on company values is your North Star.”

“Go by what people do, not by what they say.” 

“Hallway meetings, that’s where stuff gets done.”


New News Story: 

ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells


https://www.nature.com/articles/s43018-024-00821-1



How to reach us:
Scott Ogle
https://www.linkedin.com/in/scott-ogle/ 
TruLab - https://trulab.com/ 
Leukemia & Lymphoma Society - https://www.lls.org/ 

Dr. Chad Briscoe
https://www.linkedin.com/in/chadbriscoe/ 
Celerion - https://www.celerion.com/  
Gregory Austin
https://www.linkedin.com/in/gregoryaustin1/ 
ECI - https://eci-rx.com / 
Keywords: Scott Ogle, TruLab, clinical trial technology, biotech innovation, sample management in clinical trials, hiring for company culture, company values in leadership, finance...

More episodes of the podcast BioTalk Unzipped